Sickle Cell Disease Treatment Market Size Is Set To Expand With CAGR Of 17.9% By 2032
Sickle cell disease (SCD) is a genetic blood disorder that causes red blood cells to form a crescent or sickle shape, leading to blockages in blood vessels and reduced oxygen delivery to organs and tissues. The global sickle cell disease treatment market includes pharmaceuticals and other therapies used to manage the symptoms and complications of the disease, such as pain, infections, and organ damage. The market is driven by the high prevalence of SCD, especially in sub-Saharan Africa, and the increasing focus on developing targeted and curative treatments. The global market for Sickle-Cell Disease (SCD) Treatment was worth USD 1,903.2 million in…
- Date: April 13, 2023
- Author: Thomas Bretz
- Category: Taiwan News